載入...
Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever
Favipiravir (T-705) is a new anti-influenza drug approved for human use in Japan and progressing through Phase 3 clinical trials in the U.S. In addition to its potent inhibitory effects against influenza virus infection, the compound has been shown to be broadly active against RNA viruses from 9 dif...
Na minha lista:
| 發表在: | Antiviral Res |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4536130/ https://ncbi.nlm.nih.gov/pubmed/26186980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.07.003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|